Rapid tests for sexually transmitted diseases

Current Infectious Disease Reports

Volumn 8, Issue 2, 2006, Pages 115-124

  Gaydos, Charlotte Ann ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CHLAMYDIASIS; CLINICAL LABORATORY; CLINICAL PRACTICE; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; FLUORESCENCE MICROSCOPY; GONORRHEA; GRAM STAINING; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; NONHUMAN; OUTPATIENT DEPARTMENT; POINT OF CARE TESTING; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; VAGINITIS;

EID: 33645279812     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0007-7     Document Type: Review

References (67)

1. Gaydos CA, Rompalo AM: The use of urine and self-obtained vaginal swabs for the diagnosis of sexually transmitted diseases. Current Infect Dis Reports 2002, 4:148-157.
2. Gaydos CA, Quinn TC: Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice. Curr Opin Infect Dis 2005, 18:55-66.
3. Gaydos CA: Nucleic acid amplification tests for gonorrhea and chlamydia: practice and applications. In Sexually Transmitted Infections, edn 19. Edited by Zenilman JM, Moellering RC Jr. Philadelphia: Elsevier Saunders; 2005:367-386.
4. Gravitt PE, Peyton CL, Alessi TQ, et al.: Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000, 38:357-361.
5. Gravitt PE, Lacey JV, Jr., Brinton LA, et al.: Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epideriol Biomarkers Prev 2001, 10:95-100.
6. Gravitt PE, Jamshidi R: Diagnosis and management of oncogenic cervical human papillomavirus infection. In Sexually Transmitted Infections, edn 19. Edited by Zenilman JM, Moellering RC Jr. Philadelphia: Elsevier Saunders; 2005:439-458.
7. Hardick J, Yang S, Lin L, et al.: Use of the Roche LightCycler Instrument in a Real-T time PCR for Trichomonas vaginalis in urine samples from females and males. J Clin Microbiol 2003, 41:5619-5622.
8. Kaydos-Daniels SC, Miller WC, Hoffman I, et al.: Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol 2003, 41:318-323.
9. Jensen JS, Bjornelius E, Dohn B, Lidbrink P: Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis 2004, 31:499-507.
10. Palmer HM, Higgins SP, Herring AJ, Kingston MA: Use of PCR in the diagnosis of early syphilis in the United Kingdom. Sex Transm Infect 2003, 79:479-483.
11. Van Der Pol B, Quinn TC, Gaydos CA, et al.: Evaluation of the AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for the Detection of Chlamydia trachomatis. J Clin Microbiol 2000, 38:1105-1112.
12. Martin DH, Cammarata C, Van Der Pol B, et al.: Multi-center Evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for N. gonorrhoeae. J Clin Microbiol 2000, 38:3544-3549.
13. Van Der Pol B, Ferrero D, Buck-Barrington L, et al.: Multicenter evaluation of the BDProbeTec ET system for the detection of Chalmydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001, 39:1008-1016.
14. Gaydos CA, Quinn TC, Willis D, et al.: Performance of the APTIMA Combo 2 assay for the multiplex detection of Chlamydia trachomatis and Neisseria gonorrheae in female urine and endocervical swab specimens. J Clin Microbiol 2003, 41:304-309.
15. Manavi K, Young H, Clutterbuck D: Sensitivity of microscopy for the rapid diagnosis of gonorrhea in men and women and the role of gonrrhoea serovars. Int J STD AIDS 2003, 14:390-394.
16. Reichart CA, Gaydos CA, Brady WE, et al.: Evaluation of Abbott Testpack Chlamydia for detection of Chlamydia trachomatis in patients attending sexually transmitted diseases clinics. Sex Transm Dis 1990, 17:147-151.
17. Pate MS, Dixon PB, Hardy K, Crosby M, Hook EW, III: Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic. J Clin Microbiol 1998, 36:2183-2186.
18. Theodore M, Hook EW 3rd, Mableton S, et al.: Use of Thermo Biostar Optical Immunoassay (OIA) as a point of care assay for Chlamydia trachomatic and Neisseria gonorrhoeae in sexually transmitted disease clinics. Presented at the 14th Annual Meeting of the International Society for STD Research. Berlin, Germany; 2001,
19. Food and Drug Administration: http://www.fda.gov/cdrh/pdf2/k023947.pdf. Accessed October 18, 2005.
20. Gift TL, Pate M, Hook IEW, Kassler WJ: The rapid test paradox: When fewer cases detected lead to more cases treated, a decision analysis of tests for Chlamydia trachomatis. Sex Trans Dis 1999, 26:232-240.
21. Vickerman P, Watts C, Alary M, Peeling RW: Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect 2003, 79:363-368.
22. Black CM: Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997, 10:160-184.
23. Johnson J, Neas B, Parker DE, et al.: Screening for urethral infection in adolescent and young males. J Adol Health 1994, 14:356-361.
24. Marrazzo JM, Whittington WH, Celum CL, et al.: Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis 2001, 28:219-225.
25. Sellors JW, Mahony JB, Pickard L, et al.: Screening urine with a leukocyte esterase strip and subsequent chlamydial testing of asymptomatic men attending primary care practitioners. Sex Transm Dis 1993, 20:152-157.
26. Blake DR, Gaydos CA, Quinn TC: Cost-effectiveness analysis of screening adolescent males for Chlamydia trachomatis on admission to detention. Sex Transm Dis 2004, 31:85-95.
27. Madico C, Quinn TC, Rompalo A, et al.: Detection of Trichomonas vaginalis infection by polymerase chain reaction (PCR). J Clin Microbiol 1998, 36:3205-3210.
28. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM: Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and theraputic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002, 35:576-580.
29. Schwebke JR, Lawing LF: Improved detection of Trichomonas vaginalis in males using DNA amplification. J Clin Microbiol 2002, 40:3681-3683.
30. Hobbs MM, Kazembe P, Reed AW, et al.: Trichomonnas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999, 26:381-387.
31. Kaydos SC, Swygard H, Wise SL, et al.: Development and validation of a PCR-based enzyme-linked immunosorbant assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Micrbiol 2002, 40:89-95.
32. Crucitti T, Van Dyck E, Tehe A, et al.: Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 2003, 79:393-398.
33. Riley D, Roberts M, Takayama T, Krieger JN: Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol 1992, 30:465-472.
34. Rompalo AM, Gaydos CA, Shah N, et al.: Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001, 33:1455-1461.
35. Caliendo A, Jordan J, Green A, et al.: Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol 2005, 13:145-150.
36. Wendel KE, Erbelding EJ, Gaydos CA, Rompalo AM: Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD slinic. Sex Transm Infect 2003, 79:151-153.
37. Schwebke JR, Morgan S, Pinson G: Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol 1997, 35:1618-1619.
38. Wiesenfeld HC, Lowry DLB, Heine RP, et al.: Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomonas. Sex Transm Dis 2001, 28:321-325.
39. Huppert JS, Batteiger BE, Braslins P, et al.: Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005, 43:684-687.
40. Miller GA, Klausner JD, Meza R, et al.: Assessment of a rapid antigen detection system for Trichomonas vaginalis infection. Clin Diagn Lab Immunol 2003, 10:1157-1158.
41. DeMeo LR, Draper DL, McGregor JA, et al.: Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol 1996, 174:1339-1342.
42. Witt A, Petricevic L, Kaufmann U, et al.: DNA hybridization test: rapid diagnostic tool for excluding bacterial vaginosis in pregnant women with symptoms suggestive of infection. J Clin Microbiol 2002, 40:3057-3059.
43. Briselden AM, Hillier SL: Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol 1994, 32:148-152.
44. Larsson PG, Platz-Christensen JJ, Sunderstrom E: Is bacterial vaginosis a sexually transmitted disease? Int J STD AIDS 1991, 2:362-364.
45. Amsel R, Totten PA, Spiegel CA, et al.: Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic association [abstract]. Amer J Med 1983, 74:14-22.
46. Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991, 29:297-301.
47. Bradshaw CS, Morton AN, Garland SM, Horvath LB, Kuzevska I, Fairley CK: Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol 2005, 43:1304-1308.
48. Myziuk L, Romanowski B, Johnson SC: BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol 2003, 41:1925-1928.
49. Wiggins R, Crowley T, Horner PJ, et al.: Use of 5-bromo-4-chloro-3-indoyl-a-D-N-acetylneuraminic acid in a novel spot test to identify sialidase activity in vaginal swabs from women with bacterial vaginosis. J Clin Microbiol 2000, 38:3096-3097.
50. West B, Morrison L, Van Der Leoff MS, et al.: Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambia. Sex Transm Dis 2003, 30:483-489.
51. Gutman RE, Peipert JF, Weitzen S, Blume J: Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gyneco 2005, 105:551-556.
52. Posner SF, Keimova J, Aliyeva F, Duerr A: Strategies for diagnosis of bacterial vaginosis in a resource-poor setting. Int J STD AIDS 2005, 16:52-55.
53. Hay P, Tummom A, Ogunfile M, et al.: Evaluation of a novel diagnostic test for bacterial vaginosis: 'the electronic nose'. Int J STD AIDS 2003, 14:114-118.
54. Norris SJ, Pope V, Johnson RE, Larsen SA: Treponema and other human host-associated spirochetes. In Manual of Clinical Microbiology, edn 8. Edited by Murray PR, Baron EJ, Jorgensen JH, et al. Washington, D.C.: ASM Press; 2003:955-971.
55. Rein MF: Sexually transmitted diseases. In Educational Review Manual in Infectious Disease, edn 2. Edited by Cunha BA. New York, NY: Castle Connolly Graduate Medical Publishing, LTD; 2005:1-29.
56. Peeling RW, Ye H: Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ 2004, 82:439-446.
57. Fitzgerald D, Behets F, Preval J, et al.: Decreased congenital syphilis incidence in Haiti's rural Artibonite Region following decentralized prenatal screening. Am J Public Health 2003, 93:444-446.
58. Lien TX, Tien NT, Chanpong GF, et al.: Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Viet Nam. Trop Med Hygiene 2000, 62:301-309.
59. Fears MB, Pope V: Syphilis Fast Latex agglutination test, a rapid confirmatory test. Clin Diagn Lab Immunol 2001, 8:841-842.
60. Centers for Disease Control and Prevention: http://www.cdc.gov/hiv/rapid_testing/. Accessed October 14, 2005.
61. Centers for Disease Control and Prevention: http://www.cdc.gov/hiv/pubs/rt-lab.htm. Accessed October 17, 2005.
62. Constantine N, Saville R, Dax E: Rapid assays. In Retroviral Testing and Quality Assurance: Essentials for Laboratory Diagnosis. Anne Arbor, MI: Malloy Publishers; 2005, In press.
63. Sullivan E: Rapid HIV tests: federal regulatory action changes HIV testing landscape. Lab medicine 2005, 36:471-474.
64. Chou R, Smits AK, Huffman LH, et al.: Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005, 143:38-54.
65. Centers for Disease Control and Prevention: http://www.hivtestingconference.org/meeting.htm. Accessed October 17, 2005.
66. Eng TR, Butler WT: The neglected health and economic impact of STDs. In The Hidden Epidemic, Confronting Sexually Transmitted Diseases. Edited by Eng TR and Butler WT. Washington, D.C.: National Academy Press; 1997:28-68.
67. Eng TR, Discussion leaders of the IOM Workshop on the role of Health Plans in STD Prevention: Prevention of sexually transmitted diseases: A model for overcoming barriers between managed care and public health. Am J Prev Med 1999, 16:60-69.